[Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system].
Bogusławska-Jaworska
J
J
Orzechowska-Juzwenko
K
K
Pejcz
J
J
Wiela-Hojeńska
A
A
Szczepaniak
M
M
Erbel-Badeńska
J
J
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008223:Lymphoma / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage* / Q000633:toxicity; D008991:Monitoring, Physiologic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
D008727:Methotrexate
Nadzorowanie leczenia metotreksatem u dzieci z chorobami rozrostowymi układu krwiotwórczego.